In the Journals Plus

Thyroid surgery complications more common than previously believed

May 22, 2017
Thyroid surgery-specific complications developed within 1 year of thyroid surgery in 12% of adults with differentiated or medullary thyroid cancer…

Cybersecurity expert: 5 things physicians should consider to help protect data

May 22, 2017
In this guest commentary, Zuly Gonzalez, co-founder and CEO of Light Point Security and former cybersecurity expert at the National Security

Q&A: Why health care remains a target to cyberattacks like WannaCry

May 22, 2017
Earlier this month, hackers executed a worldwide ransomware attack that has impacted more than 100 countries and infected tens of thousands of…
Meeting News

Normal weight in childhood lowers males' risk for adult colon cancer

May 22, 2017
Overweight boys are at increased risk for adult colon cancer compared with normal-weight boys; however, achieving a healthy weight by young adulthood…
Meeting NewsVideo

VIDEO: New NLA president discusses updates to PCSK9 inhibitor recommendations

May 22, 2017
PHILADELPHIA — In this Cardiology Today video exclusive, James A. Underberg, MD, MS, FACPM, FACP, FNLA, new president of the National Lipid…

ARCH study: Romosozumab data show increased cardiovascular risk

May 22, 2017
Treatment with the anti-sclerostin monoclonal antibody romosozumab resulted in fewer new fractures in postmenopausal women with high-risk…
Meeting NewsPerspective

Sugar-sweetened beverage tax may lower consumption in Irish children

May 22, 2017
As expected, intake of sugar-sweetened beverages is greater among children with overweight or obesity compared with normal-weight children…
Meeting News

Recent trials advance lipidology knowledge base

May 21, 2017
PHILADELPHIA — Numerous important trials in clinical lipidology have been reported over the last year, according to a presentation at the…

Endocrine Society praises new push to regulate chemicals

May 21, 2017
The Endocrine Society applauds the reintroduction in the U.S. Senate of the Personal Care Products Safety Act, which attempts to ensure that…
Meeting News

FOURIER: Evolocumab reduces CV events regardless of baseline LDL, statin intensity

May 21, 2017
PHILADELPHIA — A subanalysis of the FOURIER trial presented at the National Lipid Association Scientific Sessions found that evolocumab was…
Meeting News

PCSK9 inhibition reduces LDL in patients on top of other therapies

May 21, 2017
PHILADELPHIA — In a real-world cohort of patients on maximally tolerated lipid-lowering therapies, PCSK9 inhibitors lowered LDL by 26% to 52%…
FDA News

Glucose monitor gets clearance in US, Europe

May 20, 2017
Smart Meter announced that its iGlucose Blood Glucose Monitoring System has received 510(k) clearance from the FDA and CE Mark in Europe, according…
Meeting News

LDL lowering more robust in men vs. women in concomitant PCSK9 inhibitor, statin therapy

May 20, 2017
PHILADELPHIA — In a small cohort of patients taking PSCK9 inhibitors, men had a lower reduction in LDL than women among those also on statin
Meeting News

PCSK9 inhibitor studies show benefit for patients with high LDL

May 20, 2017
PHILADELPHIA — Numerous studies on PCSK9 inhibitors have been completed that establish their efficacy and safety in patients with high LDL
Meeting News

New therapeutic approaches for familial chylomicronemia syndrome in development

May 20, 2017
PHILADELPHIA — A number of new therapeutic approaches may change the treatment approach for patients with familial chylomicronemia syndrome, a
Meeting News

CVD risk persists in ‘metabolically healthy’ adults with obesity

May 19, 2017
Adults with obesity deemed to be “metabolically healthy” remained at increased risk for developing cardiovascular disease when compared…
In the Journals Plus

Gonadectomy fails to affect BMD in complete androgen insensitivity syndrome

May 19, 2017
Women with complete androgen insensitivity syndrome have decreased bone mineral density at the lumbar spine and hip, which appears to be unaffected…
Meeting News

Evidence varies for nonstatin lipid-lowering therapies

May 19, 2017
PHILADELPHIA — The current evidence for PCSK9 inhibitors reducing CV events in high-risk patients is strong, but other questions surrounding…
In the Journals Plus

Physical function improves with weight loss plus aerobic, resistance exercise

May 19, 2017
Physical Performance Test scores, peak oxygen consumption and body weight were all improved with weight loss plus combined aerobic and resistance…

EndoBarrier CE Mark suspended for quality management issues

May 19, 2017
GI Dynamics announced that the CE Mark for its EndoBarrier device has been suspended due to “nonconformances related to its quality management…
Advertisement
Advertisement